July 20, 2020 / 4:03 PM / 24 days ago

France's Virbac sees full-year drop in sales as lockdowns hurt demand

(Reuters) - Veterinarian pharmaceutical company Virbac (VIRB.PA) said on Monday it expected a drop in sales for the full-year 2020, amid pressure on supplies due to the coronavirus crisis and uncertainty about demand.

The French company now forecasts a decline in revenue of between -3% and 0% for the year at constant exchange rates.

The group, which makes food, shampoos and medicines for pets and farm animals, posted second-quarter sales of 230.6 million euros (208.5 million pounds), a decline of 6.4% compared to 246.1 million euros in the year-ago period.

Reporting by Linda Pasquini; Editing by Edmund Blair

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below